Rate Video

EBMT 2018 | Endothelial dysfunction in transplant: defibrotide for VOD

Paul Richardson • 18 Mar 2018

EBMT 2018

General Defibrotide

Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks about the pooled analysis of the efficacy of defibrotide in adults with veno-occlusive disease (VOD).

Results from CC-92480-MM-001: mezigdomide combined with dexamethasone in R/R multiple myeloma

Paul Richardson • 11 Dec 2022

Mutational burden at relapse following exposure to high dose melphalan in multiple myeloma

Paul Richardson • 5 Jun 2022

The role of selinexor in the treatment of multiple myeloma

Paul Richardson • 26 Aug 2022

The safety and efficacy of isatuximab for R/R myeloma: insights from ICARIA-MM, IKEMA & CANDOR

Paul Richardson • 11 Jun 2022

Related Videos

Patient perspectives of CAR T-cell therapy

Natacha Bolaños

The multifaceted role of the advanced nurse practitioner

Challenges in the treatment of CMV

Hermann Einsele

Managing transplant patients during the COVID-19 pandemic

Christian Chabannon